Page last updated: 2024-10-17

4-aminoimidazole and Carcinoma, Hepatocellular

4-aminoimidazole has been researched along with Carcinoma, Hepatocellular in 1 studies

4-aminoimidazole: structure in first source
4-aminoimidazole : An aminoimidazole that is 1H-imidazole substituted by an amino group at position 4.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sasaki, M1
Yamamoto, K1
Ueda, T1
Irokawa, H1
Takeda, K1
Sekine, R1
Itoh, F1
Tanaka, Y1
Kuge, S1
Shibata, N1

Other Studies

1 other study available for 4-aminoimidazole and Carcinoma, Hepatocellular

ArticleYear
One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression.
    Scientific reports, 2023, 08-18, Volume: 13, Issue:1

    Topics: Carbon; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Ribonucleotides

2023